Focus on biosimilar etanercept – bioequivalence and interchangeability

por Cantini F, Benucci M
Publicado 2018

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

por Nannini C, Kaloudi O, Cassara E, Niccoli L, Cantini F
Publicado 2013

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

por Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C
Publicado 2012

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

por Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I
Publicado 2011